Oncotarget

September 14, 2021

View Archive »

About The Cover

The cover for issue 19 of Oncotarget features Figure 4, "Efficacy of nanoTCEs in vivo," by Alhallak, et al.

Table of Contents

News

Old drug, new trick: proton pump inhibitors find new purpose in cancer care

Old drug, new trick: proton pump inhibitors find new purpose in cancer care

https://doi.org/10.18632/oncotarget.28053

Natalie A. Ridge, Mohit Shiv Agarwal,  and Mohamad Hassan Fakhreddine
1861-1862
PDF  |  How to cite

Research Papers

Novel insights into the molecular mechanisms underlying risk of colorectal cancer from smoking and red/processed meat carcinogens by modeling exposure in normal colon organoids

Novel insights into the molecular mechanisms underlying risk of colorectal cancer from smoking and red/processed meat carcinogens by modeling exposure in normal colon organoids

https://doi.org/10.18632/oncotarget.28058

Matthew Devall, Christopher H. Dampier, Stephen Eaton, Mourad W. Ali, Virginia Díez-Obrero, Ferran Moratalla-Navarro, Jennifer Bryant, Lucas T. Jennelle, Victor Moreno, Steven M. Powell, Ulrike Peters,  and Graham Casey
1863-1877
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release

Nanoparticle T cell engagers for the treatment of acute myeloid leukemia

Nanoparticle T cell engagers for the treatment of acute myeloid leukemia

https://doi.org/10.18632/oncotarget.28054

Kinan Alhallak, Jennifer Sun, Barbara Muz, Amanda Jeske, Jessica Yavner, Hannah Bash, Chaelee Park, Berit Lubben, Ola Adebayo, Samuel Achilefu, John F. DiPersio,  and Abdel Kareem Azab
1878-1885
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release

Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancer

Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancer

https://doi.org/10.18632/oncotarget.28059

Brenna M. Zimmer, Michelle E. Howell, Linlin Ma, Jeffrey R. Enders, Danielle Lehman, Eva Corey, Joseph J. Barycki,  and Melanie A. Simpson
1886-1902

The antitumoral effects of chemerin are independent from leukocyte recruitment and mediated by inhibition of neoangiogenesis

The antitumoral effects of chemerin are independent from leukocyte recruitment and mediated by inhibition of neoangiogenesis

https://doi.org/10.18632/oncotarget.28056

Ingrid Dubois-Vedrenne, Diana Al Delbany, Olivier De Henau, Virginie Robert, Maxime Vernimmen, Francina Langa, Anne Lefort, Frédérick Libert, Valérie Wittamer,  and Marc Parmentier
1903-1919
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release

Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer

Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer

https://doi.org/10.18632/oncotarget.28068

Bruna Cândido Guido, Douglas Cardoso Brandão, Ana Luisa Augusto Barbosa, Monique Jacob Xavier Vianna, Lucas Faro, Luciana Machado Ramos, Fabíola Nihi, Márcio Botelho de Castro, Brenno A.D. Neto, José Raimundo Corrêa,  and Sônia Nair Báo
1920-1936
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release

High expression of Myosin 1g in pediatric acute lymphoblastic leukemia

High expression of Myosin 1g in pediatric acute lymphoblastic leukemia

https://doi.org/10.18632/oncotarget.28055

Laura A. Estrada-Abreo, Leonor Rodríguez-Cruz, Yanelly Garfias-Gómez, Janeth E. Araujo-Cardenas, Gabriela Antonio-Andrés, Alfonso R. Salgado-Aguayo, Darío Orozco-Ruiz, José Refugio Torres-Nava, Juan D. Díaz-Valencia, Sara Huerta-Yépez,  and Genaro Patiño-López
1937-1945
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release

Case Reports

Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition

Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition

https://doi.org/10.18632/oncotarget.28062

Marcel Kemper, Georg Evers, Arik Bernard Schulze, Jan Sperveslage, Christoph Schülke, Georg Lenz, Thomas Herold, Wolfgang Hartmann, Hans-Ulrich Schildhaus,  and Annalen Bleckmann
1946-1952

Research Perspectives

Towards precision oncology in angiosarcomas using next generation “omic” technologies

Towards precision oncology in angiosarcomas using next generation “omic” technologies

https://doi.org/10.18632/oncotarget.27996

Grace Fangmin Tan,  and Jason Yongsheng Chan
1953-1955
Abstract  |  PDF  |  Full Text  |  How to cite

Targeting AP-1 transcription factors by CRISPR in the prostate

Targeting AP-1 transcription factors by CRISPR in the prostate

https://doi.org/10.18632/oncotarget.27997

Maria Riedel, Huiqiang Cai, Iben C. Stoltze, Mikkel H. Vendelbo, Erwin F. Wagner, Latifa Bakiri,  and Martin K. Thomsen
1956-1961

The role of dynamic phenotypes in cancer

The role of dynamic phenotypes in cancer

https://doi.org/10.18632/oncotarget.28006

Luana S. Lenz,  and Guido Lenz
1962-1965
Abstract  |  PDF  |  Full Text  |  How to cite

Corrections

Correction: Cycling hypoxia affects cell invasion and proliferation through direct regulation of claudin1 / claudin7 expression, and indirect regulation of p18 through claudin7

Correction: Cycling hypoxia affects cell invasion and proliferation through direct regulation of claudin1 / claudin7 expression, and indirect regulation of p18 through claudin7

https://doi.org/10.18632/oncotarget.27385

Hong Liu, Feifei Jiang, Xinshan Jia, Jing Lan, Hao Guo, Erran Li, Aihui Yan,  and Yan Wang
1966-1969
Correction  |  PDF  |  How to cite


Copyright © 2024 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC